Health Research and Policy

Epidemiology Research Seminar (HRP 236)

Winter Quarter 2014
Course Director: Victor W. Henderson
Jan 7-March 11, 2014
(Tuesdays 1:30 - 3:00 p.m.)
HRP Redwood Building, T138B

Date Speaker Topic
1/7
Mark R Cullen, MD
Professor of Medicine (General Medical Disciplines)
Variation in the Female Survival Advantage Over Time and Place: Evidence for Underlying Social Determinants
1/14
Weiva Sieh, MD, PhD
Assistant Professor of Health Research & Policy (Epidemiology)
International Studies of Ovarian Cancer: Subtype-specific Etiologies and Outcomes
1/21
Victor Henderson, MD, MS
Professor of Health Research and Policy (Epidemiology) and of Neurology & Neurological Sciences
Sex Steroids Endogenous Exposures and Cognition
1/28
Chiara Sabatti, PhD
Associate Professor of Health Research and Policy (Biostatistics) and, by courtesy, of Statistics
Studying the Etiology and Symptoms of Bipolar Disorder in Central America
2/4
Peggy Reynolds, PhD, MPH
Sr Research Scientist, Cancer Prevention Institute of California
Consulting Professor of HRP (Epidemiolgy)
Light and Night, and Breast Cancer Risk in California Teachers
2/11
Seminar cancelled
--
2/18
Lorene Nelson, PhD
Associate Professor of Health Research and Policy (Epidemiology)
Lipid Lowering Medications and Motor Neuron Disease
2/25
Sally Glaser, PhD
CEO and Sr Research Scientist, Cancer Prevention Institute of California;
Consulting Professor of Health Research and Policy (Epidemiology)
Four Decades of Hodgkin Lymphoma Epidemiologic Research: Findings and Lessons for Big Data and Molecular Medicine
3/4
Soma Subramaniam, MD
Fellow, Dept of Medicine (Oncology)
Disparities in Long-term Survival from Gastric Cancer Amongst Californians of Asian Ancestry
Sheila Kumar, MD
Fellow, Dept of Medicine (Gastroenterology and Hepatology)
To be announced
3/11
Maya N White, BS
Duke University School of Medicine
Social Correlates of Sedentary Behavior in Older Adults
Robert Wong, MD, MS
Fellow, Dept of Medicine (Gastroenterology and Hepatology)
Primary Surgical Resection versus Liver Transplantation for Transplant-eligible Hepatocellular Carcinoma Patients
3/18
No Seminar
Final exams week

If you need directions or would like to be on the e-mail list, please contact Toni Ali (650-723-5456; ). Suggestions and self-nominations for seminar speakers and topics are welcome.

Stanford Medicine Resources:

Footer Links: